KRAS G12D inhibitor 1
≥98%
- Product Code: 201596
CAS:
2621928-43-4
| Molecular Weight: | 582.64 g./mol | Molecular Formula: | C₃₃H₃₂F₂N₆O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in targeted cancer therapies, particularly for tumors driven by the KRAS G12D mutation, which is common in pancreatic, colorectal, and lung cancers. This inhibitor selectively targets the mutant KRAS protein, blocking its abnormal signaling that promotes uncontrolled cell growth. By inhibiting this pathway, it helps suppress tumor progression and can enhance the effectiveness of other anticancer treatments. It is primarily used in research settings to develop precision medicines and evaluate response in preclinical models.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿135,010.00 |
+
-
|
KRAS G12D inhibitor 1
Used in targeted cancer therapies, particularly for tumors driven by the KRAS G12D mutation, which is common in pancreatic, colorectal, and lung cancers. This inhibitor selectively targets the mutant KRAS protein, blocking its abnormal signaling that promotes uncontrolled cell growth. By inhibiting this pathway, it helps suppress tumor progression and can enhance the effectiveness of other anticancer treatments. It is primarily used in research settings to develop precision medicines and evaluate response in preclinical models.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :